Cargando…
Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788019/ https://www.ncbi.nlm.nih.gov/pubmed/31601263 http://dx.doi.org/10.1186/s40880-019-0405-5 |
| _version_ | 1783458405427445760 |
|---|---|
| author | Cai, Wen Cai, Biao Zhou, Juan Chen, Yonghui Zhang, Jin Huang, Yiran Xue, Wei Huang, Jiwei |
| author_facet | Cai, Wen Cai, Biao Zhou, Juan Chen, Yonghui Zhang, Jin Huang, Yiran Xue, Wei Huang, Jiwei |
| author_sort | Cai, Wen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6788019 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67880192019-10-18 Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study Cai, Wen Cai, Biao Zhou, Juan Chen, Yonghui Zhang, Jin Huang, Yiran Xue, Wei Huang, Jiwei Cancer Commun (Lond) Letter to the Editor BioMed Central 2019-10-11 /pmc/articles/PMC6788019/ /pubmed/31601263 http://dx.doi.org/10.1186/s40880-019-0405-5 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Letter to the Editor Cai, Wen Cai, Biao Zhou, Juan Chen, Yonghui Zhang, Jin Huang, Yiran Xue, Wei Huang, Jiwei Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study |
| title | Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study |
| title_full | Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study |
| title_fullStr | Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study |
| title_full_unstemmed | Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study |
| title_short | Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study |
| title_sort | comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788019/ https://www.ncbi.nlm.nih.gov/pubmed/31601263 http://dx.doi.org/10.1186/s40880-019-0405-5 |
| work_keys_str_mv | AT caiwen comparisonofefficacyandsafetyamongaxitinibsunitinibandsorafenibasneoadjuvanttherapyforrenalcellcarcinomaaretrospectivestudy AT caibiao comparisonofefficacyandsafetyamongaxitinibsunitinibandsorafenibasneoadjuvanttherapyforrenalcellcarcinomaaretrospectivestudy AT zhoujuan comparisonofefficacyandsafetyamongaxitinibsunitinibandsorafenibasneoadjuvanttherapyforrenalcellcarcinomaaretrospectivestudy AT chenyonghui comparisonofefficacyandsafetyamongaxitinibsunitinibandsorafenibasneoadjuvanttherapyforrenalcellcarcinomaaretrospectivestudy AT zhangjin comparisonofefficacyandsafetyamongaxitinibsunitinibandsorafenibasneoadjuvanttherapyforrenalcellcarcinomaaretrospectivestudy AT huangyiran comparisonofefficacyandsafetyamongaxitinibsunitinibandsorafenibasneoadjuvanttherapyforrenalcellcarcinomaaretrospectivestudy AT xuewei comparisonofefficacyandsafetyamongaxitinibsunitinibandsorafenibasneoadjuvanttherapyforrenalcellcarcinomaaretrospectivestudy AT huangjiwei comparisonofefficacyandsafetyamongaxitinibsunitinibandsorafenibasneoadjuvanttherapyforrenalcellcarcinomaaretrospectivestudy |